Tag Archives: Burrill Report

Understanding The Shifting Patent Landscape: My Latest Podcast For The Burrill Report

While the early arrival of spring weather has many of us turning our attention to our gardends, pharmaceutical companies are facing a number of new developments in the patent landscape. In this podcast interview for  The Burrill Report, I talk about Prometheus, Myriad, the compulsory license for Bayer’s Nexvar drug in India, and the status of … Continue reading this entry

What Patent Reform Means To Biotech--My Podcast Interview On The Burrill Report

I was fortunate to be interviewed for a podcast on The Burrill Report (Life Sciences: Information • Intelligence • Insight), to discuss ”What Patent Reform Means To Biotech.” You can listen → here.… Continue reading this entry